Valuation CSL Limited Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 02:41:06 2026-07-03 EDT			5-day change	1st Jan Change
17.20 ^EUR	+2.38%		+7.50%	-27.73%

07-03	Australian shares log best week in 3 as Fed-hike bets cool; banks, miners lead	RE
06-30	ASX Midday Sector Update: Healthcare Stocks Advance, Consumer Staples Sector Struggles	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	97,314	89,299	89,052	95,184	76,024	40,458	-	-
Change	-	-8.24%	-0.28%	6.89%	-20.13%	-46.78%	-	-
Enterprise Value (EV) ¹	101,307	88,520	99,731	105,710	85,005	49,307	48,528	47,875
Change	-	-12.62%	12.66%	5.99%	-19.59%	-41.99%	-1.58%	-1.35%
P/E	41x	38.6x	40.8x	36.1x	25.4x	-45.5x	28.2x	13x
PBR	11.6x	6.13x	5.64x	5.48x	3.93x	2.48x	2.47x	2.25x
PEG	-	-4.91x	-7.25x	1.8x	1.9x	0x	-0x	0x
Capitalization / Revenue	9.44x	8.45x	6.69x	6.43x	4.89x	2.63x	2.59x	2.49x
EV / Revenue	9.83x	8.38x	7.49x	7.14x	5.46x	3.2x	3.1x	2.95x
EV / EBITDA	27.2x	24.6x	25.6x	22.3x	16.5x	9.47x	9.38x	8.83x
EV / EBIT	32.4x	30.2x	32.5x	27.7x	19x	11x	10.9x	10.3x
EV / FCF	41.8x	57.1x	72.6x	55.2x	29.1x	17.5x	16.1x	16.5x
FCF Yield	2.39%	1.75%	1.38%	1.81%	3.44%	5.7%	6.21%	6.05%
Dividend per Share ²	2.22	2.22	2.36	2.64	2.92	2.851	2.925	3.085
Rate of return	1.04%	1.2%	1.28%	1.34%	1.86%	3.37%	3.46%	3.65%
EPS ²	5.21	4.8	4.53	5.45	6.17	-1.858	3.001	6.512
Distribution rate	42.6%	46.3%	52.1%	48.4%	47.3%	-153%	97.5%	47.4%
Net sales ¹	10,310	10,562	13,310	14,800	15,558	15,392	15,635	16,244
EBITDA ¹	3,720	3,596	3,900	4,750	5,151	5,208	5,172	5,424
EBIT ¹	3,130	2,927	3,069	3,812	4,468	4,464	4,447	4,652
Net income ¹	2,375	2,255	2,194	2,642	3,002	-893.6	1,183	3,112
Net Debt ¹	3,993	-778.6	10,679	10,526	8,981	8,849	8,070	7,417
Reference price ²	213.82	185.38	184.61	196.96	157.01	84.48	84.48	84.48
Nbr of stocks (in thousands)	455,126	481,706	482,372	483,253	484,212	478,912	-	-
Announcement Date	8/17/21	8/16/22	8/14/23	8/12/24	8/18/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	16.94x	3.69x	9.97x	0.6%	66.56B
UCB	27.98x	5.76x	16.9x	0.56%	56.51B
SAMSUNG BIOLOGICS CO.,LTD.	35.25x	11.95x	22.63x	-.--%	42.98B
BIOGEN INC.	34.9x	3.71x	11.39x	-.--%	31.91B
MODERNA, INC.	-9.24x	13.4x	-8.22x	-.--%	31.65B
INCYTE CORPORATION	16.96x	3.25x	9.83x	-.--%	23.35B
INNOVENT BIOLOGICS, INC.	55.23x	6.16x	42.67x	-.--%	19.46B
SWEDISH ORPHAN BIOVITRUM AB	26.86x	5.49x	14.73x	-.--%	17.18B
BRIDGEBIO PHARMA, INC.	-35.48x	16.45x	-50.02x	-.--%	15.12B
Average	18.82x	7.76x	7.76x	0.13%	33.86B
Weighted average by Cap.	21.13x	7.11x	10.67x	0.24%